HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ji-Ye Yin Selected Research

Eukaryotic Initiation Factor-3

1/2021The effect of eIF3a on anthracycline-based chemotherapy resistance by regulating DSB DNA repair.
1/2017eIF3 Regulation of Protein Synthesis, Tumorigenesis, and Therapeutic Response.
6/2013Translational regulation of RPA2 via internal ribosomal entry site and by eIF3a.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ji-Ye Yin Research Topics

Disease

27Neoplasms (Cancer)
11/2022 - 01/2016
23Lung Neoplasms (Lung Cancer)
12/2021 - 07/2011
21Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 01/2012
10Type 2 Diabetes Mellitus (MODY)
01/2021 - 06/2008
7Insulin Resistance
07/2013 - 06/2008
6Carcinogenesis
06/2018 - 06/2013
5Neoplasm Metastasis (Metastasis)
01/2021 - 06/2013
4Seizures (Absence Seizure)
01/2019 - 04/2012
4Epilepsy (Aura)
12/2016 - 04/2012
3Ovarian Neoplasms (Ovarian Cancer)
06/2022 - 09/2015
3Glioma (Gliomas)
01/2020 - 11/2016
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2022 - 08/2014
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2021 - 06/2016
2COVID-19
09/2021 - 10/2020
2Glioblastoma (Glioblastoma Multiforme)
01/2020 - 02/2017
2Cognitive Dysfunction
01/2019 - 05/2014
2Nervous System Diseases (Neurological Disorders)
01/2019 - 08/2012
2Adenocarcinoma of Lung
08/2018 - 06/2016
1Triple Negative Breast Neoplasms
06/2022
1Fanconi Anemia (Fanconi's Anemia)
05/2022
1Hepatitis
12/2021
1Prostatic Neoplasms (Prostate Cancer)
12/2021
1Communicable Diseases (Infectious Diseases)
01/2021
1Melanoma (Melanoma, Malignant)
01/2021
1Breast Neoplasms (Breast Cancer)
01/2021
1Carcinoma (Carcinomatosis)
12/2020
1Microsatellite Instability
01/2020
1Parkinson Disease (Parkinson's Disease)
01/2019
1Alzheimer Disease (Alzheimer's Disease)
01/2019
1Schizophrenia (Dementia Praecox)
01/2019
1Huntington Disease (Huntington's Disease)
01/2019
1Stroke (Strokes)
01/2019
1Ovarian Epithelial Carcinoma
01/2018

Drug/Important Bio-Agent (IBA)

32PlatinumIBA
05/2022 - 07/2011
16Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2015
10Pharmaceutical PreparationsIBA
06/2022 - 08/2012
8Cisplatin (Platino)FDA LinkGeneric
11/2021 - 01/2014
8Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2011
8Long Noncoding RNAIBA
01/2021 - 07/2015
7Glucose (Dextrose)FDA LinkGeneric
01/2015 - 06/2008
7Insulin (Novolin)FDA Link
07/2013 - 06/2008
6MicroRNAs (MicroRNA)IBA
01/2021 - 06/2016
4Metformin (Glucophage)FDA LinkGeneric
01/2021 - 01/2015
4LDL CholesterolIBA
09/2012 - 06/2008
4CholesterolIBA
09/2012 - 06/2008
4Triglycerides (Triacylglycerol)IBA
09/2012 - 06/2008
4HDL CholesterolIBA
09/2012 - 06/2008
4Rosiglitazone (Avandia)FDA Link
09/2010 - 06/2008
3Eukaryotic Initiation Factor-3IBA
01/2021 - 06/2013
3DNA (Deoxyribonucleic Acid)IBA
01/2021 - 07/2011
3repaglinide (Prandin)FDA Link
09/2012 - 12/2010
3Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
12/2010 - 06/2008
2Complement System Proteins (Complement)IBA
12/2021 - 11/2017
2Therapeutic UsesIBA
12/2020 - 01/2020
2HMGB1 Protein (HMG1)IBA
01/2020 - 06/2014
2ResistinIBA
08/2018 - 09/2016
2Indicators and Reagents (Reagents)IBA
01/2018 - 07/2015
2Messenger RNA (mRNA)IBA
11/2017 - 01/2017
2Peptide Initiation Factors (Initiation Factor)IBA
11/2017 - 01/2014
2Carbamazepine (Tegretol)FDA LinkGeneric
07/2012 - 04/2012
2Sodium Channels (Sodium Channel)IBA
07/2012 - 04/2012
2oxidized low density lipoproteinIBA
12/2010 - 07/2008
2AdiponectinIBA
07/2009 - 06/2008
2LeptinIBA
07/2009 - 07/2008
16-methyladenineIBA
06/2022
1Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021
1Drug CombinationsIBA
12/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2021
1Concanavalin AIBA
12/2021
1Circulating Tumor DNAIBA
12/2021
1InterferonsIBA
01/2021
1Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2021
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2021
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
01/2021
1Prokaryotic Initiation Factor-3IBA
01/2021
1Untranslated RNA (Noncoding RNA)IBA
01/2021
1AnthracyclinesIBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Viral RNAIBA
01/2021
1Biological ProductsIBA
01/2021
1ProdrugsIBA
12/2020
1remdesivirIBA
10/2020
1Cancer VaccinesIBA
01/2020
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2020
1Small Interfering RNA (siRNA)IBA
01/2020
1Neuroprotective AgentsIBA
01/2019
1Dopamine (Intropin)FDA LinkGeneric
01/2019
1Dopamine Receptors (Dopamine Receptor)IBA
01/2019
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2019
1N-Methylaspartate (NMDA)IBA
01/2019
1Dizocilpine Maleate (Dizocilpine)IBA
01/2019
1Dopamine AntagonistsIBA
01/2019
1Cysteine (L-Cysteine)FDA Link
08/2018
1AfatinibIBA
01/2018

Therapy/Procedure

37Drug Therapy (Chemotherapy)
05/2022 - 07/2011
7Therapeutics
11/2022 - 05/2016
2Precision Medicine
09/2021 - 12/2014
2Radiotherapy
04/2017 - 01/2015
1Castration
12/2021
1Immunotherapy
01/2020